Quick answers
- What is Rezenopy?
- Rezenopy is a brand name of Naloxone hydrochloride, a prescription medicine. The FDA NDC Directory lists 1 Rezenopy product in 1 strength and form.
- Who makes Rezenopy?
- Scienture holds the FDA application for Rezenopy (NDA215487, approved April 19, 2024).
- Is there a generic or store brand of Rezenopy?
- Other products of Naloxone hydrochloride are listed with the FDA, but none in exactly the same strength and form as a Rezenopy product.
- Has Rezenopy been recalled?
- No recall linked to Rezenopy products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Rezenopy is
Each Rezenopy product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Naloxone hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| naloxone hydrochloride 10 mg/0.11 mL spray (nasal) | Rezenopy | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Naloxone hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA215487 | Scienture | April 19, 2024 | 1 |
Companies that list Rezenopy
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Rezenopy products.
- Scienture LLC1 product
Recalls
No recall linked to Rezenopy products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.